Toshiba showcases updated Aplio and Xario ultrasound systems

Article

Toshiba is introducing the latest improvements to its Aplio and Xario ultrasound systems at the 2005 RSNA meeting. The Aplio system has been enhanced with the company’s exclusive expanded Differential Tissue Harmonic Imaging (DTHI), while the Xario features 4D imaging.

Toshiba is introducing the latest improvements to its Aplio and Xario ultrasound systems at the 2005 RSNA meeting. The Aplio system has been enhanced with the company's exclusive expanded Differential Tissue Harmonic Imaging (DTHI), while the Xario features 4D imaging.

Expanded DTHI enables scanning of larger patients who previously couldn't be imaged with ultrasound technology, according to the company. Toshiba also reported that clinical evaluations have demonstrated that the technology can improve efficiency.

The advanced 4D technology in the Xario ultrasound system, which the company describes as "affordable," helps improve departmental efficiency as it enhances both user and patient comfort. Toshiba considers the 4D upgrade appropriate for multispecialty practices that need 3D images viewed in real-time. The Xario provides users with button-touch volume acquisition as well as simultaneous 2D and 4D display.

Other new Xario features include postprocessing tools, real-time MPR display, and a 4D measurement package. Technology migrations from the Aplio have introduced new capabilities such as Toshiba's Advanced Dynamic Flow wide-band color Doppler technique, as well as Panoramic View and Advanced Contour Tracking for cardiology applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
© 2025 MJH Life Sciences

All rights reserved.